(Q34132135)

31 July 2017

1 reference

title

Bradykinin metabolism and hypotensive transfusion reactions (English)

1 reference

31 July 2017

Cyr M

1

1 reference

31 July 2017

Eastlund T

2

1 reference

31 July 2017

Blais C Jr

3

1 reference

31 July 2017

Rouleau JL

4

1 reference

31 July 2017

Adam A

5

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

41

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

136-150

1 reference

Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Gene structure and chromosomal localization of plasma kallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

The human kallikrein gene family: a diversity of expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Kallikreins and kinins. Molecular characteristics and cellular and tissue responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Structure and functions of human kininogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Association of factor XI and high molecular weight kininogen in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Human neutrophils contain and bind high molecular weight kininogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

High molecular weight kininogen binds to unstimulated platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Kinin B1 receptors: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

The common acute lymphoblastic leukemia antigen (neutral endopeptidase-3.4.24.11) gene is located on human chromosome 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Insights into the structure and function of membrane polypeptides carrying blood group antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Novel activity of endothelin-converting enzyme: hydrolysis of bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Basic carboxypeptidases: regulators of peptide hormone activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Cloning and tissue distribution of human membrane-bound aminopeptidase P

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Cloning and functional expression of the cytoplasmic form of rat aminopeptidase P

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Purification and characterization of pig kidney aminopeptidase P. A glycosyl-phosphatidylinositol-anchored ectoenzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Development of digoxigenin-labeled peptide: application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Converting enzyme inhibitors in cardiovascular therapy: current status and future potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Endothelial protection by converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Protective effects of bradykinin on the ischaemic heart: implication of the B1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Ramiprilat increases bradykinin outflow from isolated hearts of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Effect of enalaprilat on bradykinin and des‐Arg9‐bradykinin release following reperfusion of the ischaemic rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Plasma bradykinin in angio-oedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Correlation of hypotensive effect of plasma protein fraction with prekallikrein activator activity: a clinical study in patients having open-heart surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Hypotensive reactions: a previously uncharacterized complication of platelet transfusion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Quality of platelet components: the role of suspension medium and leukocyte depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Cardiopulmonary bypass increases plasma bradykinin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41010136.X

10.1046/J.1537-2995.2001.41010136.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference